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1H NMR Detection of Vitamin C in Human Brain In Vivo
Melissa Terpstra* and Rolf Gruetter
Vitamin C (ascorbate) is well established as an essential nutri-
ent that functions as an antioxidant. Since it is present in the
human brain at detectable concentrations, this study was de-
signed to detect and quantify ascorbate in the human brain in
vivo using 1H NMR spectroscopy (MRS). Ascorbate was con-
sistently detected in all ﬁve study subjects, and was measured
using MEGA-PRESS difference editing. The in vivo resonance
pattern was consistent with that of ascorbate based on posi-
tion, line width, peak pattern, and relative intensity. Metabolites
with a potential for coediting were assessed using phantom
solutions. The putative resonances of myo-inositol, lactate,
glycerophosphocholine, phosphocholine, and phosphoethano-
lamine were detected at positions distinct from those of ascor-
bate. This study represents the ﬁrst in vivo detection of vitamin
C in the human brain using 1H MRS. A concentration of 1.3 
0.3 mol/g (mean  SD, N  4) was estimated. Magn Reson
Med 51:225–229, 2004. © 2004 Wiley-Liss, Inc.
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The importance of vitamin C (ascorbic acid) in protecting
against various diseases that have their origins in oxidative
stress has been established over the past 25 years. While
vitamin C is known primarily for its role in preventing
scurvy, it has also been credited with lowering risks of
chronic degenerative disease and cancer (1). Vitamin C
occurs physiologically as the ascorbate anion (Asc). The
brain, spinal cord, and adrenal glands have the highest Asc
concentrations of all tissues in the body, which suggests
that Asc plays a key role in brain function. Brain Asc has
been linked to neurotransmitter (glutamate) release and
uptake (2). Since vitamin C levels in the blood may be
suboptimal in large sections of the population, the recom-
mended daily allowances are being revisited (1).
1H NMR spectroscopy (MRS) is uniquely qualiﬁed for
measuring metabolite concentrations in live, intact tissue
(i.e., in vivo). Since the concentration of Asc in the human
brain (1 mol/g (2)) is high enough to be detectable, the
purpose of this study was to evaluate the feasibility of
detecting and quantifying Asc in the human brain using 1H
MRS. Edited spectroscopy is routinely utilized to uncover
coupled resonances, such as Asc from underneath stronger
resonances. Figure 1 and Table 1 illustrate the structural
and chemical shift information for Asc that is pertinent to
edited 1H MRS. The close proximity (in terms of hertz) of
the coupled resonances make edited detection of Asc par-
ticularly challenging. Increased magnetic ﬁelds (B0) are
helpful in overcoming this challenge because they result
in increased separation of coupled resonances. 1H MRS
MEGA-PRESS (sequence element for editing placed within
point resolved spectroscopy) editing was recently applied
in vivo at high ﬁelds to quantify the anti-oxidant glutathi-
one (3) and the neurotransmitter GABA (4), which have in
vivo concentrations and spectroscopic properties similar
to those of vitamin C. Therefore, this technique was opti-
mized for detection of vitamin C at 4T.
MATERIALS AND METHODS
Five normal volunteers (two males and three females, av-
erage age 21 years) gave informed consent for this study,
which was conducted according to procedures approved
by the Institutional Review Board. All experiments were
performed with a 4T, 90-cm-bore magnet (Oxford Magnet
Technology, Oxford, UK) interfaced to a Varian INOVA
spectrometer (Varian, Palo Alto, CA) equipped with gradi-
ents capable of switching to 40 mT/m in 400 s (Sonata,
Siemens, Erlangen, Germany) and a surface 1H quadrature
transceiver (5). The subjects were positioned supine inside
the magnet with the RF transceiver subjacent to their oc-
cipital lobe. First, localizer multislice rapid acquisition
with relaxation enhancement (RARE) images (TR  4.0 s,
TE  60 ms, echo train length  8, matrix  256  128,
two averages, slice thickness 2 mm, and ﬁve slices) were
obtained to select a cubic volume of interest (VOI) (3 3
3 cm3) centered on the midsagittal plane in the occipital
lobe. All ﬁrst- and second-order coils were shimmed using
FAST(EST)MAP (6), which consistently resulted in water
line widths of 8 Hz. After the spectrometer frequency was
adjusted, difference editing using MEGA-PRESS was per-
formed as described below. Each acquisition (NEX  1)
was stored separately in memory, and was then frequency-
and phase-corrected based on the individual NAA signal
prior to summation of all 512 acquisitions (TR  4.5 s).
Frequency correction was never more than 6 Hz. Process-
ing was performed using spectrometer built-in software.
MEGA-PRESS difference editing (3) was optimized for
edited detection of the C6H2 resonance of Asc (3.73 ppm),
via J-coupling to the C5H resonance (4.01 ppm). Spectra
acquired from a phantom containing Asc using stimulated
echo acquisition mode (STEAM) (7) revealed that the C4
(4.50 ppm) and C6 protons gave rise to more intense res-
onances than the C5 proton at 4.01 ppm (Fig. 1). Therefore,
the C5 proton at 4.01 ppm was chosen as the target for the
editing inversion pulse in MEGA-PRESS (8). An optimal
TE of 112 ms was determined using the Asc phantom. This
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long TE accommodated a longer editing pulse (a 40-ms
Gaussian inversion) with a more selective frequency band-
width (40 Hz). Unfortunately, this 40-ms Gaussian cen-
tered on C5H at 4.01 ppm can result in partial excitation of
resonances at 3.73 ppm, which can lead to signal contri-
butions from the more intense glutamate and glutamine H2
resonances. Figure 2 illustrates the inversion proﬁle of the
40-ms Gaussian pulse via the water suppression proﬁle of
MEGA-PRESS. Note that if complete inversion at 4.01 ppm
is accomplished in the middle of the proﬁle, a small
amount of excitation may occur at 3.73 ppm, as indicated
by the solid arrows. Shifting the offset of the inversion
pulse by approximately 20 Hz, or to 4.13 ppm, minimized
such partial excitation, although it also reduced editing
efﬁciency (dashed arrows in Fig. 2). The offset of the
editing pulse was therefore set to 4.13 ppm in order to
minimize potential subtraction artifacts at 3.73 ppm, and
to accommodate a safety margin of 10 Hz for B0 shift
during in vivo studies. RF power (B1) for the inversion
(editing) pulses was determined in each case by placing
the offset of the editing pulse on the water resonance, and
incrementing B1 until optimal water suppression was ob-
served. Water suppression using variable power radiofre-
quency pulses with optimized relaxation delays (VAPOR)
(7) and outer volume saturation were incorporated before
the MEGA-PRESS technique was applied, as described
previously (3).
Asc concentration was estimated by measuring the
heights of the maxima of edited Asc and edited aspartyl
NAA resonances both in vivo and in a phantom spectrum,
which was line-broadened to match the in vivo line widths
(i.e., accordingly line broadened), and contained known
concentrations of Asc and NAA. The intensities measured
as such in the phantom spectrum were used to calibrate
the ratio for calculating in vivo concentrations, assuming
an in vivo NAA concentration of 10 mol/g.
Potential contamination of the edited Asc signal at
3.73 ppm was evaluated by consulting metabolite assign-
ment tables (9,10). Based on known resonance positions
and J-coupling, metabolite spin systems capable of coed-
iting with Asc, and producing resonances in the spectral
region between 1 and 4 ppm, were identiﬁed. Table 2
summarizes the metabolites that may conceivably contrib-
ute resonances to the edited spectrum. Glucose (Glc) and
glycogen contribute resonances that may be coedited im-
mediately adjacent to 3.73 ppm. Glutamate (Glu) and glu-
tamine (Gln) were identiﬁed as most likely to contribute
resonances near 3.73 ppm as a result of partial excitation
by the editing pulse on every other scan. Although certain
metabolites (N-acetylaspartate (NAA), myo-inositol (Ins),
lactate (Lac), glycero-phosphocholine (GPC), phosphoryl
choline (PC), phosphoryl ethanolamine (PE), and glycerol-
phosphoethanolamine (GPE)) should be resolved from
Asc, they are capable of coediting with Asc because they
all have coupling partners within the bandwidth of the
editing pulse. In addition, the strong creatine (Cr) reso-
nance is likely to be affected by the editing pulse and
contribute a resonance near 3.9 ppm. Therefore, spectra
acquired by MEGA-PRESS difference editing were ac-
quired from phantoms (37°C, pH  7.1) containing the
aforementioned metabolites. NAA was included in most
phantoms to serve as an intensity reference and to verify
the correct editing technique. Since GPC and PC could not
be buffered (11), they were not pH-balanced or warmed.
However, it is likely that pH in these phantoms was neu-
tral, because GPC and PC are not expected to inﬂuence pH
substantially, and NAA was not included in these phan-
FIG. 1. Structure and 1H MRS spectrum of ascorbate: (a) chemical
structure and (b) 1H MRS spectrum acquired from a phantom so-
lution containing 10 mM ascorbate and 5 mM NAA (STEAM (16) with
VAPOR water suppression, 27 ml volume, TE  5 ms, TR  4.5 s,
NEX  4).
FIG. 2. Illustration of the editing pulse placement required in order
to avoid detection of noncoupled spins at 3.73 ppm in difference-
edited spectra at 4T. The inversion pulse proﬁle was measured via
the water suppression proﬁle. 1H spectra from an aqueous phantom
were acquired while the offset of the inversion pulse was incre-
mented within 75 Hz of the water frequency in 5-Hz steps. The
horizontal double arrows correspond to the frequency separation
between the Asc C6H2 at 3.73 ppm and the C5H at 4.01 ppm
(47 Hz). When the editing pulse is placed at 4.01 ppm (labeled
“on-resonance” (solid arrows)), a small amount of excitation can
occur at 3.73 ppm, especially if small frequency drifts are incurred.
The frequency of the editing pulses was therefore set to 4.13 ppm
(labeled “shifted” (dotted arrows)), which moved the resonance
positions relative to the editing proﬁle, as illustrated by the dashed
arrows and the top row labels. In the “shifted” case, complete
inversion was not accomplished at 4.01 ppm, which led to in-
creased reliability at the cost of reduced editing efﬁciency.
Table 1
1H Chemical Shifts of Ascorbate*
Group Multiplicity Chemical shift
C6H2 M 3.73
C5H M 4.01
C4H D 4.50
C3
C2
C¢O
*From (17), Table 5, page 172.
D, doublet; M, multiplet.
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toms. Table 2 details the composition of the phantoms.
Typically, physiologic concentrations of the metabolites
were used.
Finally, although the macromolecule (MM) spin system
is unlikely to contribute to the edited signal near 3.73 ppm
(11,12), one experiment was dedicated to acquiring a “me-
tabolite-nulled” spectrum (4,8). An inversion pulse was
applied before the MEGA-PRESS editing scheme, and the
time between the inversion pulse and MEGA-PRESS
(TIR  0.66 s) was set experimentally to the value where
the strongest metabolite signals (NAA, Cr, and Cho) were
nulled in subspectra. Since macromolecules recover faster
than metabolites, they appear in the metabolite-nulled
(i.e., MM) spectrum. To minimize the effect of slightly
different metabolite T1’s leading to residual metabolite
signal in the inversion-recovery (IR) measurement, a
shorter repetition time (TR  2 s) was used, which further
saturated the metabolite signals while allowing substantial
recovery of macromolecule signals. Frequency and phase
corrections were based on interleaved, inversion-naı¨ve
scans.
RESULTS
The C6H2 resonance of Asc was consistently detected at
3.73 ppm in all in vivo studies, as judged from the consis-
tent spectral pattern at 3.73 ppm, which mimicked that
measured in an accordingly line-broadened phantom spec-
trum (Fig. 3). In all four subjects measured at TR  4.5 s,
the editing resulted in resonance intensity at 3.73 ppm.
This was consistent with an Asc concentration of 1.3 
0.3 mol/g (mean SD, N 4), as judged from the relative
intensities of Asc and NAA (aspartyl moiety) in vivo and
in vitro. Thus, the in vivo resonance pattern was consis-
tent with that of Asc based on position, line width, peak
pattern, and relative concentration. The striking repeat-
ability of the edited in vivo spectra was noteworthy
(Fig. 3).
Table 2
Metabolites That Potentially Co-edit in MEGA-PRESS Editing
Experiments Designed to Detect Asc and Their Concentrations in
the Phantom Solutions*
Metabolite Group Multiplicity
Chemical
shift
Phantom
composition
Asca 1.5 mM Asc
10 mM NAA
Ins 1CH DD 3.52 7 mM Ins
2CH T 4.05 10 mM NAA
3CH DD 3.52
Lac 2CH Q 4.10 1 mM Lac
3CH3 D 1.31 10 mM NAA
GPCb 7CH2 M 4.31 1 mM GPC
8CH2 M 3.66
PC 1CH2 M 4.28 10 mM PC
2CH2 M 3.64
GPE N 3.29 Not available
O 4.11
PE 1CH2 M 3.98 2 mM PE
2CH2 M 3.22 2 mM NAA
Cr/PCr N(CH3) S 3.03 10 mM Cr
2CH2 S 3.91
Glc  6CH DD 3.83 1 mM Glc
 6CH DD 3.75 10 mM NAA
 6CH DD 3.88
 6CH DD 3.71
Glu 2CH DD 3.74 9 mM Glu
10 mM NAA
Gln 2CH T 3.75 3 mM Gln
10 mM NAA
NAAc 2CH DD 4.38 5 mM NAA
3CH2 DD 2.67
DD 2.49
*From 9, 10.
aSee Table 1 for groups, multiplicities, and chemical shifts.
bCholine moiety; the Glycerol moiety was expected to be less likely
to contribute.
cAspartate moiety.
D, doublet; DD, double-doublet; M, Multiplet; Q, quartet; S, singlet;
T, triplet.
FIG. 3. RARE image (TR  4.0 s,
TE  60 ms, echo train length  8,
matrix  256  128, two averages,
slice thickness  2 mm, ﬁve slices)
illustrating the VOI (3  3  3 cm3).
Also shown are edited in vivo 1H
MRS spectra obtained using MEGA-
PRESS (TE  112 ms, TR  4.5 s,
NEX  512) in four volunteers (a–d),
and the accordingly line-broadened
spectrum from a phantom containing
1.5 mM Asc and 10 mM NAA (e).
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Several coedited resonances that were resolved from
those of Asc were consistently detected in vivo, while
contamination from subtraction artifacts was not observed
near 3.73 ppm (Figs. 3 and 4). When compared with the in
vivo spectrum, spectra acquired from the Ins, Lac, GPC,
PC, and PE phantoms indicated that these coedited metab-
olites accounted for the corresponding coedited reso-
nances (Fig. 4). Furthermore, a resonance near 3.3 ppm
that was consistently detected but was resolved from PE,
may have been contributed by GPE. Cr contributed the
expected subtraction signal near 3.9 ppm. Using the
present methodology, coediting of resonances from Glc,
Glu, and Gln was negligible (Fig. 4). A 10-Hz B0 drift in the
direction most likely to increase signal contribution was
simulated experimentally with the Glu phantom, and re-
sulted in a small resonance of opposite sign relative to the
Asc resonance. While the expected (13) MM resonance
near 1.2 ppm was detected in the nulled (MM) spectrum,
the absence of a resonance in the vicinity of 3.7 ppm
suggested a minimal contribution of macromolecules to
the Asc resonance (Fig. 5).
DISCUSSION
In this study, vitamin C was detected by 1H MRS in the
human brain in vivo for the ﬁrst time. The 1H MRS editing
technique described herein facilitated the detection of a
strikingly reproducible spectral pattern (Fig. 3). The edited
resonance detected in vivo at 3.73 ppm clearly resembled
that detected in solutions containing Asc. Since J-modu-
lation at the long TE used in this application of MEGA-
PRESS inherently yields a speciﬁc spectral pattern for Asc,
this resemblance is strong evidence that the resonance
detected at 3.73 ppm is indeed Asc. Metabolites that could
be mistaken for vitamin C were identiﬁed and rejected as
signiﬁcant contributors to this resonance. Great care was
taken to desensitize the editing technique to contamina-
tion, even in the presence of B0 drift (4,14). In fact, editing
efﬁciency was compromised in order to ensure that gluta-
mate and glutamine would not contribute signal near
3.73 ppm, with a safety margin allowing for a 10 Hz drift
in B0. Experimental in vivo B0 drifts (	6 Hz) were well
within this safety margin. In addition to facilitating B0 and
phase correction, storing data on a scan-by-scan basis en-
abled continuous surveillance of the B0 drift.
Several coedited resonances were putatively identiﬁed
(Fig. 4) in the reproducible spectral pattern observed in
vivo. These resonances may extend the usefulness of this
technique to additional metabolites, such as GPC and GPE.
The aspartyl moiety of NAA detected here may increase
our understanding of the relative contributions from the
acetyl vs. aspartyl moiety, in addition to serving as an
internal reference. With the application of LCModel to
these edited spectra (3), GPC and GPE may be resolved
from PC and PE, respectively.
The relative intensities of the Asc and NAA aspartyl
resonances in vivo and in vitro indicated an in vivo Asc
concentration of 1 mM, in excellent agreement with that
reported in the literature (2). The application of LCModel
to the ﬁtting of edited spectra (3) should yield a more
precise value for the concentration of vitamin C, due to the
ﬁne structure of the resonances in these spectra. Although
some uncertainty may result from T2 relaxation, small
changes in vitamin C concentration may be measurable,
especially given the high repeatability and quality demon-
strated in the in vivo spectra.
FIG. 5. Metabolite-nulled experiment. The edited (metabolite) spec-
trum (top trace) was acquired as in Fig. 3 (TE 112 ms, NEX 512),
except for a 2-s TR, and interleaved with a metabolite-nulled (MM)
spectrum (TIR  0.66 s, bottom trace).
FIG. 4. Representative in vivo spectrum (A) and accordingly line-
broadened spectra acquired from phantoms containing the follow-
ing metabolites (which are capable of coediting or contributing
subtraction artifacts using MEGA-PRESS as described): Asc
 NAA
(B), mIns 
 NAA (C), Lac 
 NAA (D), GPC (E), PC (F), PE (G), Cr (H),
Gluc 
 NAA (I), Glu 
 NAA (J), Gln 
 NAA (K), and NAA (L). The
concentrations of the metabolites are listed in Table 2.
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In the present study, a high magnetic ﬁeld (4T) was
advantageous for the detection of the coupled Asc reso-
nance. Further improvements are likely to be achieved at
7T, provided the loss in sensitivity due to the shortening
in T2 does not outweigh the advantages.
Although a coupled MM resonance in the vicinity of
3.73 ppm is not suspected (12), coupling to a more recently
identiﬁed macromolecule resonance (M9) at 3.77 ppm (15)
has not been studied. Therefore, we included an IR exper-
iment in this study. The observation of the edited reso-
nance near 1.2 ppm (M2) in vivo (Fig. 5), which was
expected as a result of connectivity to 4.23 (12), demon-
strated sufﬁcient MM detection to overrule substantial
contamination from M9, which was not detected in vivo.
The appearance of a strong Asc resonance in the inter-
leaved metabolite spectrum, together with the negligible
signal near 3.7 ppm in the MM spectrum, supports our
conclusion that MM contamination of the Asc signal is
negligible with the present methods.
In vivo quantiﬁcation of Asc concentration, as described
herein, could aid researchers in revisiting the recom-
mended daily allowances of vitamin C. Since Asc is an
antioxidant, in vivo quantiﬁcation of this metabolite may
also increase our understanding of certain diseases, such
as neurodegenerative diseases and cancers, in which oxi-
dative stress has been implicated. In addition, nine com-
pounds of biological interest appear to be simultaneously
measurable using the proposed editing scheme, which in-
creases the usefulness of such editing methods.
CONCLUSIONS
This study establishes that vitamin C can be detected
reproducibly in the human brain in vivo using 1H MRS.
Concentration can by quantiﬁed by appropriate ﬁtting pro-
cedures (3), which renders the detection of changes on the
order of 5–10% conceivable. With this new measurement
technique, one can investigate the inﬂuence of dietary
vitamin C manipulations on tissue Asc concentrations in
humans, as well as the role of Asc in the pathogenesis of
several neurodegenerative disorders and cancer.
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